Company intelligence / Profile preview

Autonomix Medical, Inc.

The Woodlands, Texas, United Statesautonomix.com ↗

Ownership: Public · AMIX
Development stage: Phase 1

Overview

Positive topline results from first 15 patients' 7-day data showing significant impact on treatment of pancreatic cancer pain with maintained pain reduction. Clinically meaningful reduction of pain on the VAS Pain Scale. Responders required zero opioid use at 7 days. No procedural-related significant adverse events or unexpected complications.

Therapeutic areas: GastroenterologyPulmonologyCardiovascularOncologyNeurology
Modalities: Medical DeviceCatheter-based TechnologyRadiofrequency (RF) Ablation
Industry: Therapeutic Medical Devices

Partnerships

RF Innovations, Inc.

Financials

Market cap: $2.5M
Total revenue: $0
Enterprise value: $-978.5K

Beyond the preview

Go deeper on Autonomix Medical, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autonomix Medical, Inc..

Explore the full profile